Portability and Versatility Make the Achieva Ventilator Ideal for Home Care
ST. LOUIS, Dec. 15 /PRNewswire/ -- Mallinckrodt Inc.'s (NYSE: MKG) new
Puritan-Bennett Achieva(TM) portable volume ventilator with pressure support
offers new dimensions in versatility that make it practical for children and
adults in multiple care settings. The light and compact Achieva ventilator
with extended battery life has been sold in Europe for the past six months and
has now received regulatory clearance in the United States and Japan.
"Achieva ventilator's enhanced performance and pressure support
capabilities bring Mallinckrodt full force into the subacute market," said
Gerald R. Mattys, vice president and general manager of Mallinckrodt's
Alternate Care business. "Its simple design and logical controls provide
user-friendly operation, and the Achieva line of ventilators has all the
features necessary to cover patients across the continuum of care. This
standardization and versatility result in convenience and cost savings. The
Achieva is a direct result of Mallinckrodt's commitment to continue the
reliability and quality associated with the Puritan-Bennett brand of
ventilators."
Important features of the new Achieva ventilator include:
-- pressure support for improved patient comfort and for weaning patients
from ventilators to breathe on their own
-- exceptional battery life for extended mobility
-- simple design and logical, user-friendly controls
-- volume and pressure-limited ventilation
-- flow and pressure triggering to match patient breathing efforts,
allowing for easier breathing and greater patient comfort.
-- internal dial-in positive end -- expiratory pressure (PEEP) for
convenient ventilator operation
-- internal oxygen blending for convenient and accurate delivery of
21-100% fraction of inspired oxygen (FiO2)
-- internal memory and modem for accessing stored data, which provides for
more efficient management of patient outcomes
-- two-year warranty
Based in St. Louis, Missouri, Mallinckrodt Inc. is a global manufacturer
and marketer of specialty medical products designed to sustain breathing,
diagnose disease, and relieve pain. The company does business in more than
100 countries, operates Respiratory, Imaging and Pharmaceuticals product
groups and had fiscal 1999 net sales of $2.6 billion. The Mallinckrodt
website address is http://www.mallinckrodt.com .
CONTACT: Media, Barbara Abbett, 314-654-5230, barbara.abbett@mkg.com,
Investors, Barbara Gould, 314-654-3190, Invest@mkg.com, both of Mallinckrodt,
or Mallinckrodt Customer Service Department, 800-635-5267, ext. 2.
SOURCE Mallinckrodt
 back to top
Related links:
http://www.mallinckrodt.com
Company News On-Call:
http://www.prnewswire.com/comp/440950.html or fax,
800-758-5804, ext. 440950
CONTACT:
Media, Barbara Abbett, 314-654-5230, or
barbara.abbett@mkg.com, Investors, Barbara Gould, 314-654-3190,
or Invest@mkg.com, both of Mallinckrodt, or Mallinckrodt Customer
Service Department, 800-635-5267, ext. 2
NOTE TO EDITORS: the "2" in "FiO2" should be read as a subscript
|
